(Q31979952)

5 July 2017

title

Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen (English)

1 reference

5 July 2017

1 reference

1 reference

Paganini-Hill A

1

1 reference

5 July 2017

Clark LJ

series ordinal

2

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Breast Cancer Research and Treatment

5 July 2017

published in

1 reference

5 July 2017

volume

64

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

165-176

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Eye problems in breast cancer patients treated with tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Clock completion: an objective screening test for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

The agraphia of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Development of scoring criteria for the clock drawing task in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Screening for Alzheimer's disease by clock drawing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Clock drawing in Alzheimer's disease. A novel measure of dementia severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

On drawing impairment in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Longitudinal analysis of clock drawing in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Epidemiologic Considerations in Studies of Cognitive Function in the Elderly: Methodology and Nondementing Acquired Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Estrogen effects on cognition in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

The prevalence of dementia: a quantitative integration of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Clinical pharmacology of selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

Symptoms associated with tamoxifen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

Clock drawing as an assessment tool for dementia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

Does the Clock Drawing Test predict cognitive decline in older persons independent of the Mini-Mental State Examination? The FINE Study Group. Finland, Italy, The Netherlands Elderly

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006426132338

7 January 2021

Identifiers

DOI

10.1023/A:1006426132338

1 reference

Dimensions Publication ID

5 July 2017

1023680609

0 references

1 reference